RESUMEN
BACKGROUND: Myeloid leukemia cutis is the terminology used for cutaneous manifestations of myeloid leukemia. OBJECTIVE: The purpose of this study was to study the clinical, histopathological and immunohistochemical features of myeloid leukemia cutis. METHODS: This was a retrospective study of clinical and pathological features of 10 patients with myeloid leukemia cutis. RESULTS: One patient developed skin lesions before the onset of leukemia, seven patients developed skin infiltration within 4-72 months after the onset of leukemia, and two patients developed skin lesions and systemic leukemia simultaneously. Of these patients, five presented with generalized papules or nodules, and five with localized masses. The biopsy of skin lesions showed a large number of tumor cells within the dermis and subcutaneous fat layer. Immunohistochemical analysis showed strong reactivity to myeloperoxidase (MPO), CD15, CD43 and CD45 (LCA) in most cases. NPM1 (nucleophosmin I) and FLT3-ITD (Fms-like tyrosine kinase 3-internal tandem duplication) mutations were identified in one case. Five patients with acute myelogenous leukemia and one patient with chronic myelomonocytic leukemia died within two months to one year after the onset of skin lesions. STUDY LIMITATIONS: This was a retrospective and small sample study. CONCLUSIONS: In patients with myelogenous leukemia, skin infiltration usually occurs after, but occasionally before, the appearance of hemogram and myelogram abnormalities, and the presence of skin infiltration is often associated with a poor prognosis and short survival time. myeloid leukemia cutis often presents as generalized or localized nodules or masses with characteristic pathological and histochemical findings.
Asunto(s)
Leucemia Mieloide/patología , Infiltración Leucémica/patología , Piel/patología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Biopsia , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Nucleofosmina , Pronóstico , Estudios Retrospectivos , Factores Sexuales , Factores de TiempoRESUMEN
Leukemic infiltration of the gingival tissue associated or not with gingival enlargement may be the first manifestation of acute leukemia, despite being rarely reported in the literature. A 10-year-old female patient presented with a 1-month history of an asymptomatic, firm, and pinkish-red generalized gingival overgrowth. There was no bone resorption. Incisional biopsy of the gingival tissue was performed, with histopathological examination revealing a diffuse and hypercellular infiltration of monocytoid cells. The patient was referred to a hematologist and underwent a bone marrow biopsy, which led to a conclusive diagnosis of acute myeloid leukemia. The patient was treated with chemotherapy and we observed regression of gingival enlargement after 4 weeks from the initial therapy.
Asunto(s)
Sobrecrecimiento Gingival/patología , Leucemia Mieloide Aguda/diagnóstico , Infiltración Leucémica/patología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biopsia , Niño , Femenino , Sobrecrecimiento Gingival/diagnóstico por imagen , Sobrecrecimiento Gingival/tratamiento farmacológico , Humanos , Leucemia Mieloide Aguda/diagnóstico por imagen , Leucemia Mieloide Aguda/tratamiento farmacológico , Infiltración Leucémica/diagnóstico por imagen , Infiltración Leucémica/tratamiento farmacológico , Radiografía PanorámicaRESUMEN
Abstract: Background: Myeloid leukemia cutis is the terminology used for cutaneous manifestations of myeloid leukemia. Objective: The purpose of this study was to study the clinical, histopathological and immunohistochemical features of myeloid leukemia cutis. Methods: This was a retrospective study of clinical and pathological features of 10 patients with myeloid leukemia cutis. Results: One patient developed skin lesions before the onset of leukemia, seven patients developed skin infiltration within 4-72 months after the onset of leukemia, and two patients developed skin lesions and systemic leukemia simultaneously. Of these patients, five presented with generalized papules or nodules, and five with localized masses. The biopsy of skin lesions showed a large number of tumor cells within the dermis and subcutaneous fat layer. Immunohistochemical analysis showed strong reactivity to myeloperoxidase (MPO), CD15, CD43 and CD45 (LCA) in most cases. NPM1 (nucleophosmin I) and FLT3-ITD (Fms-like tyrosine kinase 3-internal tandem duplication) mutations were identified in one case. Five patients with acute myelogenous leukemia and one patient with chronic myelomonocytic leukemia died within two months to one year after the onset of skin lesions. Study limitations: This was a retrospective and small sample study. Conclusions: In patients with myelogenous leukemia, skin infiltration usually occurs after, but occasionally before, the appearance of hemogram and myelogram abnormalities, and the presence of skin infiltration is often associated with a poor prognosis and short survival time. myeloid leukemia cutis often presents as generalized or localized nodules or masses with characteristic pathological and histochemical findings.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Piel/patología , Leucemia Mieloide/patología , Infiltración Leucémica/patología , Pronóstico , Factores de Tiempo , Biopsia , Inmunohistoquímica , Factores Sexuales , Estudios Retrospectivos , Factores de EdadRESUMEN
BACKGROUND: Leukemia Cutis (LC) consists in neoplastic leukocytic infiltration of the skin and is strongly associated with the presence of extramedullary disease and poor prognosis. However, there are few studies in the literature regarding this entity. We perform a retrospective study of 27 mexican patients in order to analyze the clinical features and prognosis of LC in Mexico, and a brief review of the literature. METHODS: Cases diagnosed as LC by skin biopsy were selected from the database of the Department of Dermatology of National Institute of Medical Science and Nutrition Salvador Zubirán. Cases were searched between the dates of January 1993 and December 2013. RESULTS: Twenty-seven cases which were histologically confirmed with cutaneous leukemic infiltrate were included. Of these patients 60% were male and the mean age at diagnosis was 42 yr (19 to 80 yr). The predominant tipe of LC was acute myeloid leukemia (AML) with 48% of the cases. Nodular neoformations were the main clinical manifestation with 63% of the cases. The mean interval between the diagnosis of LC and death was 10 months (CI 95%). CONCLUSIONS: The presence of LC is a marker of poor prognosis and can precede the relapse of systemic leukemia. Cutaneous infiltration may be the first or the only sign of progression, so doctors should be familiar with the clinical manifestations of this disease.
Asunto(s)
Leucemia Linfoide/patología , Leucemia Mieloide/patología , Infiltración Leucémica/patología , Piel/patología , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Leucemia Linfoide/epidemiología , Leucemia Mieloide/epidemiología , Leucemia Mieloide Aguda/mortalidad , Leucemia Mieloide Aguda/patología , Infiltración Leucémica/mortalidad , Masculino , México/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos , Distribución por Sexo , Adulto JovenRESUMEN
Abstract Wolf's isotopic response designates the appearance of two subsequent unrelated dermatoses in the same anatomic location. We report the case of a 51-year-old man with a medical history of chronic lymphocytic leukemia without known extra-hematopoietic involvement. The patient developed a disseminated papulo-vesiculous eruption, diagnosed as varicella. Few days after recovering, an erythematous and violaceous papular dermatosis with histopathological examination compatible with leukemic infiltration appeared on the scars of previous herpetic lesions. Complete remission was obtained under systemic corticotherapy, without cutaneous recurrence or blastic transformation. Wolf's isotopic response is attributed to a localized immunologic imbalance following a certain stimulus. In this patient, herpetic infection acted as a local spur for inaugural cutaneous leukemic infiltration, with no impact on the prognosis for the underlying disease.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Piel/patología , Leucemia Linfocítica Crónica de Células B/patología , Varicela/patología , Enfermedades Cutáneas Virales/patología , Infiltración Leucémica/patología , Inmunohistoquímica , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Varicela/tratamiento farmacológico , Resultado del Tratamiento , Enfermedades Cutáneas Virales/tratamiento farmacológico , Infiltración Leucémica/tratamiento farmacológico , Dermis/patología , Herpes Zóster/patologíaRESUMEN
Bullous leukemia cutis is an uncommon clinical manifestation of cutaneous infiltration by leukemic cells, from B-cell chronic lymphocytic leukemia. We present the case of a 67-year-old, female, chronic lymphocytic leukemia patient. She was taking chlorambucil and developed facial edema with erythema and warmth, misjudged as facial cellulitis. Two days later, she developed bullous lesions in the arms, legs, neck and face. The histopathology of facial and bullous lesions confirmed leukemia cutis. All lesions disappeared following the administration of rituximab combined with cycles of fludarabine and cyclophosphamide. Although soft tissue infections are common complications in patients undergoing chemotherapy, leukemia cutis can also resemble cellulitis.
Asunto(s)
Celulitis (Flemón)/patología , Dermatosis Facial/patología , Leucemia Linfoide/patología , Infiltración Leucémica/patología , Enfermedades Cutáneas Vesiculoampollosas/patología , Anciano , Antineoplásicos Alquilantes/uso terapéutico , Ciclofosfamida/uso terapéutico , Diagnóstico Diferencial , Dermatosis Facial/tratamiento farmacológico , Femenino , Humanos , Inmunohistoquímica , Leucemia Linfoide/tratamiento farmacológico , Infiltración Leucémica/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológicoRESUMEN
Wolf's isotopic response designates the appearance of two subsequent unrelated dermatoses in the same anatomic location. We report the case of a 51-year-old man with a medical history of chronic lymphocytic leukemia without known extra-hematopoietic involvement. The patient developed a disseminated papulo-vesiculous eruption, diagnosed as varicella. Few days after recovering, an erythematous and violaceous papular dermatosis with histopathological examination compatible with leukemic infiltration appeared on the scars of previous herpetic lesions. Complete remission was obtained under systemic corticotherapy, without cutaneous recurrence or blastic transformation. Wolf's isotopic response is attributed to a localized immunologic imbalance following a certain stimulus. In this patient, herpetic infection acted as a local spur for inaugural cutaneous leukemic infiltration, with no impact on the prognosis for the underlying disease.
Asunto(s)
Varicela/patología , Leucemia Linfocítica Crónica de Células B/patología , Infiltración Leucémica/patología , Enfermedades Cutáneas Virales/patología , Piel/patología , Varicela/tratamiento farmacológico , Dermis/patología , Herpes Zóster/patología , Humanos , Inmunohistoquímica , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Infiltración Leucémica/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Enfermedades Cutáneas Virales/tratamiento farmacológico , Resultado del TratamientoRESUMEN
INTRODUCTION: To describe the type and frequency of cutaneous manifestations of leukemia. METHODS: Observational, descriptive study. We included patients over 16 years of age, with confirmed diagnosis of leukemia from the Hematology and Dermatology Departments of the outpatient clinic and from in-patients. Patients with bone marrow transplantation were excluded. A complete history and physical examination of the skin and appendages was performed, with biopsy and cultures if required. The cutaneous manifestations were classified as infection or drug-related, leukemic infiltration, associated dermatosis to leukemia and non-specific lesions. Descriptive statistics was employed. RESULTS: We included 142 patients (62 females, 80 males) with the following diagnoses: acute myeloid leukemia (n=36), acute lymphoblastic leukemia (n=52), chronic myeloid leukemia (n=21), chronic lymphocitic leukemia (n=30) and hairy cells leukemia (n=3). 42% of patients (n=60) presented some dermatoses. There were 36 non-specific dermatoses, 21 drug-related, 20 infectious, 3 infiltrative and none associated. CONCLUSIONS: Cutaneous manifestations directly related to leukemia are frequent, being the non-specific ones, the most commonly observed. However, a thorough dermatologic examination is important in these patients as part of an overall evaluation.
Introducción: el objetivo de este estudio es describir la frecuencia y tipo de manifestaciones cutáneas en pacientes con leucemia.Métodos: estudio observacional, descriptivo. Se incluyeron pacientes mayores de 16 años, con diagnóstico confirmado de leucemia, de los departamentos de Hematología y Dermatología procedentes de la consulta externa u hospitalizados. Se excluyeron los pacientes trasplantados de médula ósea. Se les efectuó historia clínica y revisión dermatológica completa de la piel y anexos, toma de biopsias y cultivos en caso de requerirlo. Las manifestaciones cutáneas se clasificaron en manifestaciones secundarias a procesos infecciosos o medicamentos, infiltración leucémica, dermatosis asociadas a la leucemia y lesiones inespecíficas. Se empleó estadística descriptiva.Resultados: Se incluyeron 142 pacientes con los siguientes diagnósticos: leucemia mieloide aguda (n = 36 pacientes), leucemia linfoblástica aguda (n = 52), leucemia mieloide crónica (n = 21), leucemia linfocítica crónica (n = 30), leucemia de células peludas (n = 3). El 42.25 % de los pacientes (n = 60) presentaron hallazgos positivos para alguna dermatosis. Se encontraron 36 dermatosis inespecíficas, 21 medicamentosas, 20 infecciosas, 3 infiltrativas y ninguna asociada.Conclusiones: las manifestaciones cutáneas directamente relacionadas a leucemia son frecuentes, siendo las inespecíficas las más comúnmente observadas. Sin embargo, el examen dermatológico completo es importante en estos pacientes como parte de su evaluación integral.
Asunto(s)
Leucemia/complicaciones , Enfermedades de la Piel/etiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Estudios Transversales , Femenino , Humanos , Leucemia/tratamiento farmacológico , Leucemia/patología , Infiltración Leucémica/patología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Piel/patología , Enfermedades de la Piel/inducido químicamente , Enfermedades de la Piel/patología , Adulto JovenRESUMEN
The clinical differential diagnosis of erythroderma is extensive and includes both benign and malignant causes. The authors present an exceptional case of erythroderma secondary to pre-B-cell lymphoblastic leukemia cutis, with diagnostic findings on biopsy.
Asunto(s)
Dermatitis Exfoliativa/patología , Infiltración Leucémica/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras B/complicaciones , Piel/patología , Anciano , Dermatitis Exfoliativa/etiología , Dermatitis Exfoliativa/metabolismo , Resultado Fatal , Femenino , Humanos , Infiltración Leucémica/etiología , Piel/químicaRESUMEN
Pancreatic infiltration of leukemic cells is a very rare manifestation at the onset of acute lymphoblastic leukemia (ALL) in childhood. Pancreatic enlargement in this situation is unusual and pancreatic involvement is often associated with biliary obstruction, cholestasis and pancreatitis. We report a 3-month-old girl who presented with asymptomatic leukemic infiltration of the pancreas, demonstrated by US with heterogeneous pancreatic enlargement associated with multiple hypoechogenic lesions, without cholestasis. Although these manifestations are rare, ALL should be considered a cause of pancreatic enlargement.
Asunto(s)
Infiltración Leucémica/diagnóstico por imagen , Infiltración Leucémica/patología , Páncreas/diagnóstico por imagen , Páncreas/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico por imagen , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Ultrasonografía/métodos , Femenino , Humanos , LactanteRESUMEN
We present a 71 year old male patient with previous records of Chronic Lymphocytic Leukaemia who presented with a tumoral skin lesion. Histological and immunohistochemical studies confirmed the Leukaemia Cutis diagnosis. The patient underwent treatment with clorambucile and systemic steroids with remision of both haemathological and skin manifestation. The patient is still under close clinical follow up and remission continues eight months so far.
Asunto(s)
Leucemia Linfocítica Crónica de Células B/patología , Infiltración Leucémica/patología , Piel/patología , Anciano , Antineoplásicos Alquilantes/uso terapéutico , Biopsia , Clorambucilo/uso terapéutico , Humanos , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Infiltración Leucémica/tratamiento farmacológico , Masculino , RecurrenciaRESUMEN
Presentamos un paciente varón de 71 años con lesión tumoral en piel y antecedente de LLC. Los estudios histopatológicos y de inmunohistoquímica confirman el diagnóstico de Leucemia Cutis. Se realiza tratamiento con Clorambucilo y corticoides vía oral, remitiendo su enfermedad hematológica y cutánea. Actualmente luego de ocho meses del diagnóstico de LC, el paciente se encuentra libre de enfermedad.
We present a 71 year old male patient with previous records of Chronic Lymphocytic Leukaemia who presented with a tumoral skin lesion. Histological and immunohistochemical studies confirmed the Leukaemia Cutis diagnosis. The patient underwent treatment with clorambucile and systemic steroids with remision of both haemathological and skin manifestation. The patient is still under close clinical follow up and remission continues eight months so far.
Asunto(s)
Humanos , Masculino , Anciano , Leucemia Linfocítica Crónica de Células B/patología , Infiltración Leucémica/patología , Piel/patología , Antineoplásicos Alquilantes/uso terapéutico , Biopsia , Clorambucilo/uso terapéutico , Inmunohistoquímica , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Infiltración Leucémica/tratamiento farmacológicoAsunto(s)
Linfoma de Burkitt/patología , Conjuntiva/patología , Infiltración Leucémica/patología , Antineoplásicos/uso terapéutico , Biopsia , Linfoma de Burkitt/líquido cefalorraquídeo , Linfoma de Burkitt/tratamiento farmacológico , Niño , Humanos , Imagen por Resonancia Magnética , Masculino , Radioterapia Adyuvante , Recurrencia , Trasplante de Células Madre , Tomografía Computarizada por Rayos XRESUMEN
A case of a 20-years-old black man from Salvador, Bahia with HTLV-I associated T cell lymphoma is presented. In spite of the absence of splenomegaly and leukemia, the patient had a marked cephalic tumoral infiltrationassociated with axillary tumors in a pattern not yet described in adult T cell lymphoma. Peripheral blood involvement was observed later on in the course of thedisease. The patient underwent chemotherapy but died seven monts after diagnosis
Asunto(s)
Humanos , Masculino , Adulto , Infiltración Leucémica/patología , Leucemia-Linfoma de Células T del Adulto/patología , Piel/patología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Bleomicina/administración & dosificación , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Cara/patología , Infiltración Leucémica/tratamiento farmacológico , Leucemia-Linfoma de Células T del Adulto/inmunología , Leucemia-Linfoma de Células T del Adulto/tratamiento farmacológico , Prednisona/administración & dosificación , Vincristina/administración & dosificaciónRESUMEN
A case of a 20-years-old black man from Salvador, Bahia with HTLV-I associated T cell lymphoma is presented. In spite of the absence of splenomegaly and leukemia, the patient had a marked cephalic tumoral infiltration associated with axillary tumors in a pattern not yet described in adult T cell lymphoma. Peripheral blood involvement was observed later on in the course of the disease. The patient underwent chemotherapy but died seven months after diagnosis.
Asunto(s)
Leucemia-Linfoma de Células T del Adulto/patología , Infiltración Leucémica/patología , Piel/patología , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Bleomicina/administración & dosificación , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Cara/patología , Humanos , Leucemia-Linfoma de Células T del Adulto/tratamiento farmacológico , Leucemia-Linfoma de Células T del Adulto/inmunología , Infiltración Leucémica/tratamiento farmacológico , Masculino , Prednisona/administración & dosificación , Pronóstico , Vincristina/administración & dosificaciónRESUMEN
Se revisa la literatura médica mundial y nacional sobre la infiltración leucémica de los riñones, y se comprueba la existencia de pocas publicaciones al respecto. Se realiza un estudio de los signos radiológicos y anatomopatológicos de la misma, y se demuestra que es más frecuente en la niñez. Se revisa un total de 28 pacientes ingresados en el hospital pediátrico docente "Eliseo 'Noel' Caamaño", de Matanzas, en un período de 7 años, y se comprueba que existe infiltración renal en 12 de ellos. El tipo de leucemía que predominó fue la mieloblástica aguda. Se presentan 2 paciente en quienes se demuestran los signos señalados(AU)